Fig. 3From: Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical studyIllustration of the pathway for 225 patients after [18F]FDG-PET/CT and biopsy/follow-up, reflecting the results of the scan and final diagnostic workup. Footnotes: Metastatic breast cancer (MBC). *Ten patients suspected of MBC were also suspected of incidental findings. †A final diagnosis was not obtained due to an impossible biopsy procedure or the result of the biopsy being inconclusiveBack to article page